Table 2 Univariate and multivariate analyses of infection-related hospitalization after prostate biopsy
Variable | Univariate | Multivariatea | ||
|---|---|---|---|---|
OR (95 % CI) | p value | OR (95 % CI) | p value | |
Age | ||||
< 70 | 1.0 | |||
≥ 70 | 0.83 (0.38–1.89) | 0.655 | ||
BMI | 0.99 (0.86–1.13) | 0.825 | ||
Diabetes mellitus | 0.72 (0.22–2.40) | 0.595 | ||
Prostate volume | 1.00 (0.98–1.02) | 0.941 | ||
IPSS | ||||
Mild | 1.0 | 1.0 | ||
Moderate | 0.36 (0.36–2.60) | 0.947 | 0.94 (0.35–2.52) | 0.936 |
Severe | 3.37 (1.32–8.60) | 0.011 | 3.18 (1.24–8.13) | 0.016 |
Year of prostate biopsy | ||||
2003–2007 | 1.0 | |||
2008–2013 | 0.71 (0.34–1.49) | 0.364 | ||
Number of biopsy cores taken | ||||
≤ 12 | 1.0 | |||
≥ 13 | 1.29 (0.60–2.76) | 0.514 | ||
Antibiotic prophylaxis | ||||
Quinolone | 1.0 | 1.0 | ||
third-generation Cephalosporin | 0.20 (0.10–0.42) | <0.001 | 0.21 (0.10–0.44) | <0.001 |